0 items USD 0.00Search
Your search for "current partnering pharmaceutical deals alliances 2014" gave back 173711 results.
Pharmaceutical Deal Trends (2010–2015) and In-Depth Analysis of Recent Deal Activity Summary GBI Research’s latest report, "Pharmaceutical Deal...
CBR Pharma Insights
October 2015
Price: USD 2,995.00
Ectonucleotide Pyrophosphatase/Phosphodiesterase Family Member 2 (Autotaxin or Extracellular Lysophospholipase D or ENPP2 or EC 3.1.4.39) - Pipeline...
Catalog:
Global Markets Direct
November 2018
Price: USD 3,500.00
The report entitled „Antibody-Drug Conjugates 2014 – A Business, Technology & Pipeline Analysis“ published in January 2014 is based on the...
Catalog:
La Merie Publishing
January 2014
Price: USD 2,298.00
Ectonucleotide Pyrophosphatase/Phosphodiesterase Family Member 2 (Autotaxin or Extracellular Lysophospholipase D or ENPP2 or EC 3.1.4.39) - Pipeline...
Catalog:
Global Markets Direct
May 2018
Price: USD 3,500.00
Astex Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report Summary Astex Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance...
MarketLine
November 2022
Price: USD 175.00
Rigel Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report Summary Rigel Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance...
MarketLine
December 2022
Price: USD 175.00
Yifan Pharmaceutical Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Yifan Pharmaceutical Co Ltd - Strategy, SWOT and Corporate Finance...
MarketLine
June 2022
Price: USD 175.00
Achillion Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report Summary Achillion Pharmaceuticals, Inc. - Strategy, SWOT and Corporate...
MarketLine
February 2020
Price: USD 175.00
BioMarin Pharmaceutical Inc. - Strategy, SWOT and Corporate Finance Report Summary BioMarin Pharmaceutical Inc. - Strategy, SWOT and Corporate...
MarketLine
December 2022
Price: USD 175.00
Sunesis Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report Summary Sunesis Pharmaceuticals, Inc. - Strategy, SWOT and Corporate...
MarketLine
November 2020
Price: USD 175.00
Apotex, Inc. - Strategy, SWOT and Corporate Finance Report Summary Apotex, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of...
MarketLine
November 2022
Price: USD 175.00
Hikma Pharmaceuticals PLC - Strategy, SWOT and Corporate Finance Report Summary Hikma Pharmaceuticals PLC - Strategy, SWOT and Corporate Finance...
MarketLine
January 2023
Price: USD 175.00
Actelion Pharmaceuticals Ltd - Strategy, SWOT and Corporate Finance Report Summary Actelion Pharmaceuticals Ltd - Strategy, SWOT and Corporate...
MarketLine
December 2020
Price: USD 175.00
Vertex Pharmaceuticals Incorporated - Strategy, SWOT and Corporate Finance Report Summary Vertex Pharmaceuticals Incorporated - Strategy, SWOT and...
MarketLine
January 2023
Price: USD 175.00
Recordati S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Recordati S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of...
MarketLine
January 2023
Price: USD 175.00
